Nasdaq · CIK 0001035267 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Intuitive Surgical, Inc.
ISRG chart by TradingView
PRICE HISTORY
LIVE · NASDAQISRG chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $10.1B
- EBITDA
- $3.6B
- FREE CASH FLOW
- $2.5B
- EPS
- $7.87
- GROSS MARGIN
- 66.00%
- ROIC
- —
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
45.3x
+241%11.4x93.1x
⤢
P / SALES (TTM)
12.9x
+252%3.1x23.1x
⤢
P / BOOK
7.8x
+352%1.5x11.5x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
—
⤢
FCF YIELD (TTM)
2.27%
-8.4pp0.26%12.31%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$2.9B
+324%⤢
EBITDA (DERIVED)
$1.0B
+257%⤢
NET INCOME
$0.8B
+288%⤢
EPS (DILUTED)
$2.29
+29%⤢
REVENUE GROWTH YOY
18.54%
+2.7pp-22.46%71.81%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
32.79%
-4.4pp-10.75%42.56%
⤢
RETURN ON CAPITAL
—
⤢
RETURN ON EQUITY (TTM)
17.28%
+4.2pp10.90%18.96%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN67.78%
OPERATING MARGIN33.60%
NET MARGIN28.29%
FCF MARGIN32.79%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.9B
+274%⤢
STOCK-BASED COMP
$0.2B
+349%⤢
CAPITAL EXPENDITURE
$0.1B
+646%⤢
SHARES OUTSTANDING
0.36B
+200%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$2.8B
+170%⤢
TOTAL DEBT
—
⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 89.33%INSIDERS 0.51%OTHER / RETAIL 10.16%3,140 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 8.51% | 30.1M | $11.39B | -1.4% |
| Vanguard Capital Management LLC | 6.53% | 23.1M | $8.74B | NEW |
| State Street Corporation | 4.49% | 15.8M | $6.00B | +0.9% |
| Price (T.Rowe) Associates Inc | 3.54% | 12.5M | $4.74B | -0.3% |
| Invesco Ltd. | 3.17% | 11.2M | $4.24B | -7.5% |
| Geode Capital Management, LLC | 2.40% | 8.5M | $3.21B | +2.9% |
| Capital World Investors | 2.28% | 8.0M | $3.05B | +2.4% |
| Vanguard Portfolio Management LLC | 2.05% | 7.2M | $2.74B | NEW |
| Morgan Stanley | 1.72% | 6.1M | $2.30B | +5.5% |
| FMR, LLC | 1.55% | 5.5M | $2.07B | -16.7% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.